Search
01/04/2024
Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB) (vol 76, pg 961, 2023)
Juzga-Corrales, C, Ayerza-Casas, A, Figueras-Coll, M, Escribà-Bori, S, Plata-Izquierdo, B, Collell, R, González-Marín, MA, Siurana, JM, Sorlí, M, de la Torre, LA, Teodoro-Marín, S, Rodríguez, M, Domínguez-García, O, Rellán, S, Manso, B, López-Abel, B, Alvarez-Pérez, R, Portillo-Márquez, M, Rezola, E, Centeno-Malfaz, F, Solana-Gracia, R, Rojo-Sombrero, H, Cantero-Tejedor, MT, Riaño, B, Tejero-Hernández, MA, Jiménez-Casso, M, Pérez-Pardo, AM, Moriano-Gutiérrez, A, Marrero-Calvo, M, Fernández, MT, Salido-Peracaula, C, Bravo, MJ, Gutiérrez-Larraya, F, Sabaté-Rotés, A. Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB) (vol 76, pg 961, 2023). REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(4)DOI:10.1016/j.rec.2023.12.011. PMID:. IF:4.900(Q1/2D).
01/04/2024
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
Martinez-Molina, C, Feliu, A, Park, HS, Juanes, A, Diaz-Torne, C, Vidal, S, Corominas, H. Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?. Journal of Clinical Medicine. 2024; 13(8)DOI:10.3390/jcm13082355. PMID:38673626. IF:2.900(Q1/2D).
01/04/2024
Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study
Ramos, JR, Grande, AS, Perrín, MRS, Requejo, CC, Vega, MH, Vinardell, LL, Martín, AG, Baeta, YC, González, AJM, Díez, MA, Giner, SC, Carranza, SH, Diáz, AS, Riera, MP, Liendo, LM, Blanch, CT, Amallo, AR, Blanco, CC. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study. Revista Espanola de Quimioterapia. 2024; 37(2)DOI:10.37201/req/138.2023. PMID:38372121. IF:2.200(Q3/6D).
01/04/2024
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
Daudén, E, Escario, E, Martos-Cabrera, L, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera, R, de la Cueva, P, Martorell, A, Ballesca, F, Belinchón, I, Carretero, G, Rodríguez, L, Romero-Maté, A, Pujol-Montcusí, J, Salgado, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandrés, O, Feltes, R, Riera-Monroig, J, Garrido, J, Llamas-Velasco, M. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(4)DOI:10.1111/ijd.16915. PMID:38168847. IF:3.200(Q1/3D).